FBIO Historical PE Ratio image   This FBIO PE ratio history page last updated 8/15/2022
FBIO PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2022
8/11/2022
1.29-0.10-0.18NA
Q1 2022
5/12/2022
0.80-0.100.292.8
Q4 2021
3/28/2022
1.420.020.304.7
Q3 2021
11/15/2021
3.360.540.2812.0
Q2 2021
8/16/2021
2.82-0.17-0.33NA
Q1 2021
5/16/2021
NA-0.09-0.21NA
Q4 2020
3/31/2021
3.530.00-0.19NA
Q3 2020
11/9/2020
2.34-0.07-0.76NA
Q2 2020
8/10/2020
3.32-0.05-0.91NA
Q1 2020
5/11/2020
2.64-0.07-1.37NA
Q4 2019
3/16/2020
1.14-0.57-1.84NA
Q3 2019
11/12/2019
1.63-0.22-1.82NA
Q2 2019
8/9/2019
1.34-0.51-1.97NA
Q1 2019
5/10/2019
1.78-0.54-1.96NA
Q4 2018
3/18/2019
1.99-0.55-1.91NA
Q3 2018
11/9/2018
1.10-0.37-1.58NA
Q2 2018
8/9/2018
2.13-0.50-1.88NA
Q1 2018
5/10/2018
3.72-0.49-1.81NA
Q4 2017
3/16/2018
5.16-0.22-1.62NA
Q3 2017
11/9/2017
3.78-0.67-1.84NA
Q2 2017
8/9/2017
4.05-0.43-1.49NA
Q1 2017
5/10/2017
3.62-0.30-1.37NA
Q4 2016
3/16/2017
3.61-0.44-1.38NA
Q3 2016
11/9/2016
2.50-0.32-1.25NA
Q2 2016
8/9/2016
2.96-0.31-1.39NA
Q1 2016
5/10/2016
3.00-0.31-1.24NA
Q4 2015
3/15/2016
2.96-0.31-1.24NA
Q3 2015
11/9/2015
2.88-0.46NANA
Q2 2015
8/10/2015
3.15-0.16NANA
Q1 2015
5/11/2015
3.04-0.31NANA
FBIO Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2022
8/11/2022
1.29-0.10-0.40NA
Q1 2022
5/12/2022
0.80-0.10-0.40NA
Q4 2021
3/28/2022
1.420.020.0817.8
Q3 2021
11/15/2021
3.360.542.161.6
Q2 2021
8/16/2021
2.82-0.17-0.68NA
Q1 2021
5/16/2021
NA-0.09-0.36NA
Q4 2020
3/31/2021
3.530.000.00NA
Q3 2020
11/9/2020
2.34-0.07-0.28NA
Q2 2020
8/10/2020
3.32-0.05-0.20NA
Q1 2020
5/11/2020
2.64-0.07-0.28NA
Q4 2019
3/16/2020
1.14-0.57-2.28NA
Q3 2019
11/12/2019
1.63-0.22-0.88NA
Q2 2019
8/9/2019
1.34-0.51-2.04NA
Q1 2019
5/10/2019
1.78-0.54-2.16NA
Q4 2018
3/18/2019
1.99-0.55-2.20NA
Q3 2018
11/9/2018
1.10-0.37-1.48NA
Q2 2018
8/9/2018
2.13-0.50-2.00NA
Q1 2018
5/10/2018
3.72-0.49-1.96NA
Q4 2017
3/16/2018
5.16-0.22-0.88NA
Q3 2017
11/9/2017
3.78-0.67-2.68NA
Q2 2017
8/9/2017
4.05-0.43-1.72NA
Q1 2017
5/10/2017
3.62-0.30-1.20NA
Q4 2016
3/16/2017
3.61-0.44-1.76NA
Q3 2016
11/9/2016
2.50-0.32-1.28NA
Q2 2016
8/9/2016
2.96-0.31-1.24NA
Q1 2016
5/10/2016
3.00-0.31-1.24NA
Q4 2015
3/15/2016
2.96-0.31-1.24NA
Q3 2015
11/9/2015
2.88-0.46-1.84NA
Q2 2015
8/10/2015
3.15-0.16-0.64NA
Q1 2015
5/11/2015
3.04-0.31-1.24NA
Quotes delayed 20 minutes

Email EnvelopeFree FBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Fortress Biotech (FBIO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

FBRX PE Ratio History
FDMT PE Ratio History
FEMY PE Ratio History
FGEN PE Ratio History
FHTX PE Ratio History
FIXX PE Ratio History
FLDM PE Ratio History
FLGT PE Ratio History
FLXN PE Ratio History
FMTX PE Ratio History
On this page we presented the FBIO PE Ratio History information for Fortress Biotech' stock. The average FBIO PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 9.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average FBIO PE ratio history based on this TTM earnings result method is 6.5. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this FBIO PE ratio history result, against the recent PE: when this page was posted on 8/12/2022, the most recent closing price for FBIO had been 1.27, and the most recent quarterly earnings result, annualized, was 0.08. Meanwhile, the most recent TTM earnings summed to 0.29. From these numbers, we calculate the recent FBIO PE on 8/12/2022 based on annualized quarterly EPS was 15.9. Based on FBIO's history, that recent PE is elevated relative to the historical average, with the recent PE 63.9% higher than the historical average PE across our data set for Fortress Biotech. Looking at the recent FBIO PE on 8/12/2022 based on TTM EPS, we calculate the ratio at 4.4. Based on FBIO's history, that recent PE is low relative to the historical average, with the recent PE 32.3% lower than the average PE across our Fortress Biotech data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on FBIO or any other given stock, valuation analysis for FBIO can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Fortress Biotech PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for FBIO. Thanks for visiting, and the next time you need to research FBIO PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: CJES Historical Stock Prices, D Dividend Growth Rate, GNMA Dividend History.

 

FBIO PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.